CREKA peptide acetate, a self-assembling short peptide (sequence Cys-Arg-Glu-Lys-Ala), specifically recognizes and binds to overexpressed fibrin, effectively targeting disease sites such as cancer, myocardial ischemia-reperfusion, and atherosclerosis. CREKA peptide acetate holds potential for research in the field of nanomedicine technology.
Target-Kategorie:
Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
